Biodyne Co. Ltd.
Biodyne Co., Ltd. engages in the development, manufacture, and sale of liquid-based cytology (LBC) equipment and reagent kits for cancer diagnosis in South Korea. The company offers PATHPLORER solution, which preserves and fixes the collected cells; PATHPLORER LBC system, an equipment for processing liquid cytology samples for cancer diagnosis. It exports its products to Japan, Russia, Portugal, … Read more
Biodyne Co. Ltd. - Asset Resilience Ratio
Biodyne Co. Ltd. (314930) has an Asset Resilience Ratio of 23.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2024)
This chart shows how Biodyne Co. Ltd.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Biodyne Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩10.00 Billion | 23.02% |
| Total Liquid Assets | ₩10.00 Billion | 23.02% |
Asset Resilience Insights
- Good Liquidity Position: Biodyne Co. Ltd. maintains a healthy 23.02% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Biodyne Co. Ltd. Industry Peers by Asset Resilience Ratio
Compare Biodyne Co. Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Beijing Centergate Technologies Holding Co Ltd
SHE:000931 |
Medical Instruments & Supplies | 0.06% |
|
Blue Sail Medical Co Ltd
SHE:002382 |
Medical Instruments & Supplies | 5.12% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 35.75% |
|
Allmed Medical Products Co Ltd Class A
SHE:002950 |
Medical Instruments & Supplies | 3.78% |
|
Inix Technologies Holdings Bhd
KLSE:0094 |
Medical Instruments & Supplies | 0.06% |
|
Focus Point Holdings Bhd
KLSE:0157 |
Medical Instruments & Supplies | 2.30% |
|
Careplus Group Bhd
KLSE:0163 |
Medical Instruments & Supplies | 4.91% |
|
LKL International Bhd
KLSE:0182 |
Medical Instruments & Supplies | 0.38% |
Annual Asset Resilience Ratio for Biodyne Co. Ltd. (2018–2024)
The table below shows the annual Asset Resilience Ratio data for Biodyne Co. Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 46.68% | ₩20.70 Billion | ₩44.35 Billion | +1.84pp |
| 2023-12-31 | 44.84% | ₩19.72 Billion | ₩43.99 Billion | -0.81pp |
| 2022-12-31 | 45.65% | ₩20.73 Billion | ₩45.41 Billion | -9.91pp |
| 2021-12-31 | 55.56% | ₩25.46 Billion | ₩45.82 Billion | +39.78pp |
| 2020-12-31 | 15.78% | ₩3.98 Billion | ₩25.24 Billion | +7.97pp |
| 2019-12-31 | 7.81% | ₩1.82 Billion | ₩23.25 Billion | -3.15pp |
| 2018-12-31 | 10.97% | ₩1.42 Billion | ₩12.92 Billion | -- |